HENRY SCHEIN, INC.

HSIC

CIK 0001000228 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-27) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$3.44B
↑+7.7% +$246Mvs FY2024 (Q4)
Operating Income
$163M
↑+5.2% +$8Mvs FY2024 (Q4)
Net Income
$101M
↑+7.4% +$7Mvs FY2024 (Q4)
Gross Profit
$1.06B
↑+7.0% +$70Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
59/100
  • Profitability
    50ROIC 15.0% (10% = solid, 20%+ = moat)
  • Liquidity
    44Current Ratio 1.38 (above 1.5 = solid)
  • Leverage
    87D/E 0.26 (under 0.5 = conservative)
  • Efficiency
    79Asset Turnover 1.23x (1.0+ = capital-efficient)
  • Growth
    42Revenue YoY +7.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    51Op Margin 4.7% · trend +0.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project HSIC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

4%

Trailing 3-yr CAGR was 4.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$68.56
Total enterprise IV
$8.34B
Diluted shares
0.12B
Terminal PV
$5.92B (71% of total)
Year-5 FCF
$697M
YearProjected FCFDiscounted PV
+1$596M$542M
+2$620M$512M
+3$645M$484M
+4$670M$458M
+5$697M$433M
Terminal$9.53B$5.92B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$139M
investment in PP&E
Stock buybacks (TTM)
$850M
share count reduction
Stock-based comp (TTM)
$39M
non-cash dilution

Balance sheet · 2025-12-27

latest filed snapshot
Total assets
$11.21B
everything owned
Total liabilities
$6.42B
everything owed
Stockholders' equity
$3.25B
shareholder claim
Net debt
$890M
LT debt minus cash

Recent performance · 68 quarters

Revenue↑+7.7% +$246M
$3.44B
Net Income↑+7.4% +$7M
$101M
Free Cash Flow↑+101.2% +$170M
$338M
Operating Margin↓-0.1pts
4.7%

Drill down